Streetbeat News

Products Services

Electronic Arts Inc. (NASDAQ:EA) has announced the release date for NHL 24 as Oct. 6, 2023. The game, which features Cale Makar as the cover athlete, introduces the new Exhaust Engine, powered by Frostbite, and includes the Sustained Pressure System and the Goalie Fatigue System. NHL 24 also features enhanced cross-play functionality.

Portfolio Pulse from Franca Quarneti

August 21, 2023 | 6:33 pm

ATVI

Activision Blizzard's Overwatch 2 game received a surge of negative reviews following its recent launch on Steam. The complaints were mainly about free-to-play monetization, game balance, lack of promised PvE content, and a toxic player base. The game's director, Aaron Keller, acknowledged the feedback and emphasized the team's commitment to improving the game with additional content.

Portfolio Pulse from Franca Quarneti

August 21, 2023 | 6:18 pm

NIO

NIO shares are trading higher after the company reportedly implemented measures to boost production of the ES6 following a brief five-day hiatus.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2023 | 6:10 pm

AMD

INTC

NVDA

VMW

At the VMware Explore 2023 event, Advanced Micro Devices (AMD) showcased its AMD EPYC CPUs, AMD Pensando data processing units (DPUs), and adaptive computing products. The company highlighted the superior performance of its 4th Gen AMD EPYC 9654 CPUs and Pensando DPU compared to standard NICs and Intel's Xeon 8490H-based servers. However, analysts are divided over AMD's potential in the artificial intelligence market against Nvidia. AMD's Q2 2023 earnings per share beat estimates, but revenue fell 17.56% YoY.

Portfolio Pulse from Anusuya Lahiri

August 21, 2023 | 6:05 pm

AMZN

SNAP

Snap Inc's AI feature, My AI, experienced a bug causing it to post its own story and stop responding to users, raising privacy concerns. Amazon.com Inc announced it will use generative AI to enhance product reviews, summarizing common themes in a short paragraph. This is expected to improve the buying experience and combat fake reviews.

Portfolio Pulse from Upwallstreet

August 21, 2023 | 5:38 pm

ACB

CGC

CLVR

CRON

CURLF

TLRY

Curaleaf (OTCQX: CURLF) plans to start selling recreational marijuana in Germany by the end of 2024, capitalizing on the country's recent move to legalize cannabis. Germany, with its population of nearly 84 million, is expected to become one of the world's largest recreational cannabis markets. Other notable companies eyeing the German market include Tilray, Inc. (NASDAQ: TLRY), Aurora Cannabis (NASDAQ: ACB), Canopy Growth (NASDAQ: CGC), Cronos Group (NASDAQ: CRON), and Clever Leaves (NASDAQ: CLVR).

Portfolio Pulse from Maureen Meehan

August 21, 2023 | 5:20 pm

AMZN

CDW

CDW Corporation (NASDAQ:CDW) has entered into a four-year Strategic Collaboration Agreement (SCA) with Amazon Web Services (AWS). The collaboration aims to deliver comprehensive solutions and services leveraging AWS to help organizations harness the full potential of the cloud adoption journey. CDW will provide enhanced expertise and scale in all segments including Corporate, Small Business and Public, and will collaborate with AWS to develop new solutions across key focus areas.

Portfolio Pulse from Happy Mohamed

August 21, 2023 | 5:15 pm

MRNA

NSSC

PANW

SLGG

TMBR

U.S. stocks traded mixed with the Dow Jones falling over 100 points while NASDAQ and S&P 500 rose. Palo Alto Networks reported better-than-expected Q4 earnings and issued a strong billings outlook, causing its shares to rise by 17%. Timber Pharmaceuticals' shares spiked by 98% as it agreed to be acquired by LEO US Holding. Moderna's shares also rose by 9% after announcing positive preliminary clinical trial data for its updated COVID-19 vaccine. Meanwhile, shares of Super League Gaming, Napco Security Technologies, and PARTS iD fell significantly.

Portfolio Pulse from Lisa Levin

August 21, 2023 | 4:45 pm

HCM

HUTCHMED's Phase 3 trial ESLIM-01 evaluating the use of sovleplenib for primary immune thrombocytopenia (ITP) in China has met its primary and secondary endpoints. The company plans to submit the New Drug Application (NDA) by the end of 2023. The National Medical Products Administration of China (NMPA) granted Breakthrough Therapy designation to sovleplenib in January 2022, which may lead to priority review for its use in ITP. HUTCHMED retains all rights to sovleplenib worldwide.

Portfolio Pulse from Vandana Singh

August 21, 2023 | 4:28 pm

TSHA

GordonMD® Global Investments LP has participated in a $150 million private placement financing for Taysha Gene Therapies, Inc. (NASDAQ:TSHA). The funds will be used to fund clinical development of TSHA-102 in Rett syndrome and support program activities for TSHA-120 in giant axonal neuropathy (GAN).

Portfolio Pulse from Happy Mohamed

August 21, 2023 | 3:30 pm